Targeting HIV-1 envelope glycoprotein trimers to B cells by using APRIL improves antibody responses.
Journal of Virology.
Times cited: 31
How can HIV-type-1-Env immunogenicity be improved to facilitate antibody-based vaccine development?.
AIDS Research and Human Retroviruses.
Times cited: 43